Your browser doesn't support javascript.
loading
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas.
Sonner, Jana K; Deumelandt, Katrin; Ott, Martina; Thomé, Carina M; Rauschenbach, Katharina J; Schulz, Sandra; Munteanu, Bogdan; Mohapatra, Soumya; Adam, Isabell; Hofer, Ann-Cathrin; Feuerer, Markus; Opitz, Christiane A; Hopf, Carsten; Wick, Wolfgang; Platten, Michael.
Afiliación
  • Sonner JK; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany.
  • Deumelandt K; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany.
  • Ott M; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany.
  • Thomé CM; DKTK CCU Neurooncology, DKFZ , Heidelberg, Germany.
  • Rauschenbach KJ; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany.
  • Schulz S; Centre for Applied Research "Applied Biomedical Mass Spectrometry" (ABIMAS), Hochschule Mannheim , Mannheim, Germany.
  • Munteanu B; Centre for Applied Research "Applied Biomedical Mass Spectrometry" (ABIMAS), Hochschule Mannheim , Mannheim, Germany.
  • Mohapatra S; Junior Group Brain Cancer Metabolism, DKFZ , Heidelberg, Germany.
  • Adam I; Junior Group Brain Cancer Metabolism, DKFZ , Heidelberg, Germany.
  • Hofer AC; Research Group Immune Tolerance, DKFZ , Heidelberg, Germany.
  • Feuerer M; Research Group Immune Tolerance, DKFZ , Heidelberg, Germany.
  • Opitz CA; Junior Group Brain Cancer Metabolism, DKFZ, Heidelberg, Germany; Department of Neurology and National Center of Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Hopf C; Centre for Applied Research "Applied Biomedical Mass Spectrometry" (ABIMAS), Hochschule Mannheim , Mannheim, Germany.
  • Wick W; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany; Department of Neurology and National Center of Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Platten M; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ, Heidelberg, Germany; Department of Neurology and National Center of Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Department of Neurology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Oncoimmunology ; 5(12): e1240858, 2016.
Article en En | MEDLINE | ID: mdl-28123877
Palabras clave